ACE acts by converting the inactive angiotensin I to active angiotensin II, a potent vasoconstrictor member of the renin-angiotensin system (RAS) and an essential peptide for the pathophysiology of HF [17] and cardiac fibrosis [18]. The gene discussed is ACE; the disease is hydrops fetalis.